Review of melatonin for viral infections and post-infection sequelae. The SARS-CoV-2 virus can cause oxidative stress, mitochondrial dysfunction, LINE1 derepression, and changes to m6A RNA modifications. These effects can increase viral replication and suppress host immune responses. Melatonin employs antioxidant and non-antioxidant mechanisms to modulate viral phase separation, restore mitochondrial function, suppress LINE1 derepression, and regulate m6A modifications. Through these diverse actions, melatonin may inhibit acute viral infection and replication, as well as prevent post-infection complications. The authors suggest melatonin could be an important therapeutic adjuvant for SARS-CoV-2 infection and post-infection recovery.
Reviews covering melatonin for COVID-19 include1-21.
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.